VYNE Therapeutics Inc (VYNE) insider trading
Every open-market stock purchase and sale by VYNE Therapeutics Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Patrick G Lepore (Insider), $43.8K, 21 months ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $25.45 on Jul 24, 2026.
Recent VYNE insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jul 23, 2026 | David Domzalski (CEO) | Sold (not open market) | $71.3K |
| Jul 23, 2026 | Tyler Zeronda (CFO) | Sold (not open market) | $20.2K |
| Jul 23, 2026 | Mutya Harsch (C-suite exec) | Sold (not open market) | $20.2K |
| Jul 23, 2026 | Iain Stuart (C-suite exec) | Sold (not open market) | $13.8K |
| May 29, 2026 | David Domzalski (CEO) | Bought (not open market) | $9.5K |
| Mar 31, 2026 | David Domzalski (CEO) | Sold (not open market) | $8.5K |
| Mar 31, 2026 | Tyler Zeronda (CFO) | Sold (not open market) | $2.4K |
| Mar 31, 2026 | Mutya Harsch (C-suite exec) | Sold (not open market) | $2.4K |
| Mar 31, 2026 | Iain Stuart (C-suite exec) | Sold (not open market) | $1.7K |
| Dec 31, 2025 | David Domzalski (CEO) | Sold (not open market) | $7.4K |
| Dec 31, 2025 | Tyler Zeronda (CFO) | Sold (not open market) | $4.6K |
| Dec 31, 2025 | Mutya Harsch (C-suite exec) | Sold (not open market) | $2.1K |
| Dec 31, 2025 | Iain Stuart (C-suite exec) | Sold (not open market) | $1.4K |
| Dec 12, 2025 | Sharon Barbari (Insider) | Bought (not open market) | — |
| Dec 12, 2025 | Elisabeth Sandoval Little (Insider) | Bought (not open market) | — |
| Dec 12, 2025 | Steven L Basta (Insider) | Bought (not open market) | — |
| Dec 12, 2025 | Patrick G Lepore (Insider) | Bought (not open market) | — |
Who's trading VYNE
- Tyler Zeronda, CFO: other filings, last Jul 23, 2026
- David Domzalski, CEO: other filings, last Jul 23, 2026
- Mutya Harsch, C-suite exec: other filings, last Jul 23, 2026
- Iain Stuart, C-suite exec: other filings, last Jul 23, 2026
- Elisabeth Sandoval Little, Insider: other filings, last Dec 12, 2025
- Sharon Barbari, Director: other filings, last Dec 12, 2025
- Patrick G Lepore, Director: other filings, last Dec 12, 2025
- Steven L Basta, Director: other filings, last Dec 12, 2025
Get free alerts when an insider at VYNE Therapeutics Inc files a new trade →